文献速递临床试验与 GCP

轻症急性胰腺炎患者早期口服抗炎饮食:一项随机对照试验的研究方案

Early oral anti-inflammatory diet in patients with mild acute pancreatitis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2026-02-10

本研究为单中心随机对照试验,纳入72例轻症急性胰腺炎患者(修订版亚特兰大标准),每组36例。干预组在48小时内启动口服抗炎饮食(每日膳食炎症指数DII评分小于0),对照组接受常规管理(医生指导启动口服,从清流质逐步过渡到全流质再到低脂软食)。主要结局包括炎症生物标志物、营养指标和肠道菌群(16S rRNA测序),次要结局为平均住院时间和费用。

要点

  • 单中心随机对照试验,纳入72例轻症急性胰腺炎患者,每组36例。
  • 干预组48小时内启动口服抗炎饮食(DII评分<0),对照组常规阶梯饮食。
  • 主要结局为炎症标志物、营养指标及肠道菌群,次要结局为住院时间和费用。

核心结论

  • 本研究的阳性结果可能为轻症急性胰腺炎患者的早期营养支持提供新的临床实践指南。
  • 作为单中心研究,仍需通过更大样本量的多中心研究进一步验证。

研究设计与样本

  • 单中心随机对照试验,纳入72例轻症急性胰腺炎患者(修订版亚特兰大标准),随机分为两组,每组36例。

关键数值与推荐

  • 干预组:48小时内启动口服;每日食物摄入遵循研究组制定的膳食炎症指数(DII)评分小于0的饮食。
  • 对照组:医生指导启动口服,从清流质到全流质再到低脂软食阶梯式推进。
  • 主要结局:炎症生物标志物、营养指标、肠道菌群(16S rRNA测序);次要结局:平均住院时间和费用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作为单中心研究,仍需通过更大样本量的多中心研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The anti-inflammatory diet exerts its effects by suppressing inflammatory mediators and modulating gut microbiota to reduce inflammation. However, its safety and efficacy in early nutritional management for patients with mild pancreatitis remain to be evaluated. OBJECTIVE: This study aims to evaluate both the efficacy and safety of an early introduction of an anti-inflammatory diet in patients with mild acute pancreatitis. METHODS: This single-center randomized controlled trial enrolled 72 patients with mild acute pancreatitis (revised Atlanta criteria), randomly assigning 36 patients to each group. The intervention group received an early oral anti-inflammatory diet protocol featuring: ① oral intake initiation within 48 h; ② the daily food intake followed a diet with a Dietary Inflammatory Index (DII) score of less than 0, as formulated by the research group. The control group received conventional management: physician-directed oral intake initiation and a stepwise advancement from "clear liquid to full liquid to low-fat soft diet." Primary outcomes included inflammatory biomarkers, nutritional indicators, and gut microbiota (16S rRNA sequencing). Secondary outcomes were average hospital stay and costs. DISCUSSION: The positive findings of this study may offer novel clinical practice guidelines for early nutritional support in patients with mild acute pancreatitis. However, as a single-center study, further validation through multi-center studies with larger sample sizes is still required. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400094056. https://www.chictr.org.cn/index.html .

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yang X, Zhang L, Lin H, et al. Early oral anti-inflammatory diet in patients with mild acute pancreatitis: study protocol for a randomized controlled trial. Trials. 2026. PMID: 41668182. doi:10.1186/s13063-025-09408-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。